| Name | Title | Contact Details |
|---|
Welcome to the official LinkedIn page for Canadian Blood Services. We manage the national supply of blood, blood products, stem cells and related services for all the provinces and territories (excluding Quebec). We also lead an integrated, interprovincial system for organ donation and transplantation for all of Canada. We are dedicated to improving patient outcomes through the manufacturing and delivery of safe, relevant, quality products and services to Canadians. Generous donors, volunteers, corporate partners and employees make this possible. We are grateful for their ongoing commitment to helping save or improve the lives of many Canadians. Canadian Blood Services operates an integrated, pan-Canadian service delivery model. Our national scope, infrastructure and governance make us unique in the Canadian healthcare landscape. Canadian Blood Services was founded in 1998, based on recommendations from the Krever Report on the tainted blood scandal. We are regulated as a biologics manufacturer by Health Canada and primarily funded by the provincial and territorial ministries of health. Canadian Blood Services is a not-for-profit charitable organization whose mission is to operate Canada’s blood supply in a manner that gains the trust, commitment and confidence of all Canadians by providing a safe, secure, cost-effective, affordable and accessible supply of quality blood, blood products and their alternatives. Canadian Blood Services strives to create informative and engaging communities on social media.
Art Reach Foundation Inc is a Atlanta, GA-based company in the Non-Profit sector.
The Carter Center Inc is a Atlanta, GA-based company in the Non-Profit sector.
America Red Cross - Florida's Coast to Coast Chapter is a Daytona Beach, FL-based company in the Non-profit sector.
The National Organization for Rare Disorders, a 501(c)(3) organization, is an independent patient advocacy organization dedicated to helping individuals with rare diseases and the organizations that serve them. NORD, along with its 280 patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient support services. NORD serves all stakeholders in the rare disease community, including patients and their families, patient organizations, researchers, medical professionals, medical students, and companies developing orphan products. NORD also works closely with many government agencies, most notably the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). All NORD programs are focused on one ultimate goal -- to improve the lives of individuals and families affected by rare diseases. NORD is the official sponsor of Rare Disease Day in the U.S., an observance day held on the last day of February each year worldwide. Its goals are to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families.